Skip to main content
Figure 1 | Cancer & Metabolism

Figure 1

From: Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations

Figure 1

Fibroblast growth factor receptor (FGFR)4 deficiency reduced mammary tumor incidence. The age-matched C57BL/6 J KO-Tg and Tg mice as indicated were examined for the presence of palpable breast tumor foci that were further confirmed by pathological examination on tissue sections under microscope. The incidence rate of breast tumor was determined monthly as the percentage of the whole population in each group (Tg, 218 mice; KO-Tg, 206 mice). Experimental data from three cohorts are expressed as mean ± SD; P <0.05. KO, FGFR4 knockout; Tg, MMTV-TGFα transgenic mouse.

Back to article page

Cancer & Metabolism

ISSN: 2049-3002